Nordsjællands Hospital, Hillerød

Hillerød 3400

0 studies enrolling now · 3 studies all time

What they study most

COVID, COVID-19, Diabetes Mellitus, Type 1, Obesity, Overweight, SARS (Severe Acute Respiratory Syndrome), SARS-CoV-2, Type 1 Diabetes

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight — Running, not enrolling
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) — Completed
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) — Completed